Edwards Lifesciences Corporation Common Stock

Financials

Flusso di cassa derivante dalle attività operative -127.5 M280.4 M290.2 M573.7 M450.9 M43.8 M 1.36 B Flussi di cassa derivanti dalle attività di investimento -576.7 M85.3 M-172.1 M-427.8 M-198.3 M-92.8 M -891 M Liquidità derivante dalle attività di finanziamento 28.6 M-258 M52.7 M-740.1 M-11.4 M-451.2 M -1.15 B Liquidità libera -127.5 M280.4 M240.9 M516.2 M353.5 M-21.1 M 1.09 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

EW

Financials

Edwards Lifesciences Corporation Common Stock

Notizie

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

Il CVP di Edwards Lifesciences Donald Bobo Jr. vende azioni per $2 mln

Il titolo azionario di Edwards Lifesciences raggiunge il massimo a 52 settimane a 87,89 USD

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Il CVP di Edwards Lifesciences Wayne Markowitz vende azioni per $47.279

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)

CVP TAVR di Edwards Lifesciences vende azioni per 170.160 dollari

Edwards Lifesciences nomina Doretta Mistras nuovo CFO

Top Research Reports for Philip Morris, Honeywell & Starbucks